Expert: David Wright
David W. Wright, MD, is associate professor of emergency medicine and director, Emergency Neurosciences at Emory University School of Medicine. Dr. Wright is actively involved in both the preclinical and clinical assessment of traumatic brain injury (TBI) and stroke.
Dr. Wright is the Project Leader for the Phase II clinical trial, ProTECT™ (Progesterone for TBI, experimental clinical treatment) and is now the Principal Investigator for the planning grant proposal in preparation for a Phase III clinical trial. He is also the Principal Investigator of the Emory Hub for the Neurological Emergencies Treatment Trials Network.
Wright is interested in the development of novel technologies for medical applications, particularly mild TBI, and works collaboratively with the Georgia Institute of Technology Department of Biomedical Engineering. He is the co-inventor of the DETECT™ system, (Display Enhanced Testing for Concussions and TBI). The DETECT™ system is a novel, portable, self-contained device developed for the sideline assessment of concussion and other forms of mild cognitive impairment such as the early stages of Alzheimer's disease.
Media Inquiries: email@example.com, 404-727-3870
More on David Wright »
June 18, 2012
Feb. 17, 2012
Past Media Coverage »
- Atlanta Business Chronicle - "Grady testing breakthrough for traumatic brain injury"
- BBC News - "Sex hormone progesterone to get head injury trial"
- CNN - "Device seeks to detect concussions during games"
- USA Today - "Progesterone to the Rescue"